{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:41:51Z","timestamp":1793432511799,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple reports on the co-existence of autoimmune diseases and myasthenia gravis (MG) have raised considerable concern. Therefore, we reviewed autoimmune diseases in MG to explore their clinical presentations and determine whether the presence of autoimmune diseases affects the disease severity and treatment strategies for MG. We reviewed all the major immune-mediated coexisting autoimmune conditions associated with MG. PubMed, Embase and Web of Science were searched for relevant studies from their inception to January 2023. There is a higher frequency of concomitant autoimmune diseases in patients with MG than in the general population with a marked risk in women. Most autoimmune comorbidities are linked to AChR-MG; however, there are few reports of MuSK-MG. Thyroid disorders, systemic lupus erythematosus, and vitiligo are the most common system autoimmune diseases associated with MG. In addition, MG can coexist with neurological autoimmune diseases, such as neuromyelitis optica (NMO), inflammatory myopathy (IM), multiple sclerosis (MS), and autoimmune encephalitis (AE), with NMO being the most common. Autoimmune diseases appear to develop more often in early-onset MG (EOMG). MS coexists more commonly with EOMG, while IM coexists with LOMG. In addition, MG complicated by autoimmune diseases tends to have mild clinical manifestations, and the coexistence of autoimmune diseases does not influence the clinical course of MG. The clinical course of neurological autoimmune diseases is typically severe. Autoimmune diseases occur most often after MG or as a combined abnormality; therefore, timely thymectomy followed by immunotherapy could be effective. In addition, thymoma-associated AChR MG is associated with an increased risk of AE and IM, whereas NMO and MS are associated with thymic hyperplasia. The co-occurrence of MG and autoimmune diseases could be attributed to similar immunological mechanisms with different targets and common genetic factor predisposition. This review provides evidence of the association between MG and several comorbid autoimmune diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1223322","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:03:30Z","timestamp":1694721810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases"],"prefix":"10.3389","volume":"14","author":[{"given":"Ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25438","article-title":"Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients","volume":"55","author":"Rivner","year":"2017","journal-title":"Muscle Nerve."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1031890","article-title":"Poly-autoimmunity in patients with myasthenia gravis: A single-center experience","volume":"48","author":"Evoli","year":"2015","journal-title":"Autoimmunity."},{"key":"B7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864777","article-title":"Thymus functionality needs more than a few TECs","volume":"13","author":"Bhalla","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","volume":"1412","author":"Cron","year":"2018","journal-title":"Ann NY Acad Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_935_20.","article-title":"Thymectomy for myasthenia gravis: A pathological analysis","volume":"65","author":"Bansod","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology","volume":"11","author":"Fichtner","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","article-title":"A study of comorbidities in myasthenia gravis","volume":"120","author":"Misra","year":"2020","journal-title":"Acta Neurol Belg."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.173638","article-title":"Coexistence of autoimmune diseases and autoantibodies in patients with myasthenia gravis","volume":"64","author":"Tamer","year":"2016","journal-title":"Neurol India"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102368","DOI":"10.1016\/j.autrev.2019.102368","article-title":"Thyroid disorders in patients with myasthenia gravis: A systematic review and meta-analysis","volume":"18","author":"Song","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.537","article-title":"Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course","volume":"6","author":"Kubiszewska","year":"2016","journal-title":"Brain Behav"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity."},{"key":"B20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joim.12310","article-title":"The autoimmune spectrum of myasthenia gravis: a Swedish population-based study","volume":"277","author":"Fang","year":"2015","journal-title":"J Intern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13549","article-title":"Comorbidities in older patients with myasthenia gravis - Comparison between early- and late-onset disease","volume":"145","author":"Klimiec-Moskal","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2010.539307","article-title":"Frequency of autoimmune diseases in myasthenia gravis: a systematic review","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.790941","article-title":"Comorbid autoimmune diseases in patients with myasthenia gravis: A retrospective cross-sectional study of a chinese cohort","volume":"12","author":"Shi","year":"2021","journal-title":"Front Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09498-4","article-title":"Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review","volume":"268","author":"Chamberlain","year":"2021","journal-title":"J Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.06.027","article-title":"Co-occurrence of multiple sclerosis and myasthenia gravis: A case report and review of immunological theories","volume":"34","author":"Dehbashi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.01.011","article-title":"Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy","volume":"317","author":"Hor","year":"2018","journal-title":"J Neuroimmunol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.05.004","article-title":"Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review","volume":"48","author":"Huang","year":"2019","journal-title":"Semin Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"731569","DOI":"10.1155\/2010\/731569","article-title":"Aquaporin expression in normal and pathological skeletal muscles:a brief review with focus on AQP4","volume":"2010","author":"Wakayama","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.07.016","article-title":"Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis","volume":"227","author":"Chan","year":"2010","journal-title":"J Neuroimmunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e318247bc91","article-title":"Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis","volume":"18","author":"Ogaki","year":"2012","journal-title":"Neurologist."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/cjn.2021.508","article-title":"Complement inhibition in myasthenia gravis and neuromyelitis optica spectrum disorder","volume":"13","author":"Dodig","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2018.06.018","article-title":"Pathologies du spectre de la neuromy\u00e9lite optique \u00e0 aquaporine-4 associ\u00e9es \u00e0 la myasth\u00e9nie auto-immune : une revue de la litt\u00e9rature [Neuromyelitis optica spectrum disorders positive for anti-AQP4 antibody associated with myasthenia gravis: A literature review]","volume":"42","author":"Brignol","year":"2019","journal-title":"J Fr Ophtalmol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511431728","article-title":"Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature","volume":"18","author":"Jarius","year":"2012","journal-title":"Mult Scler."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.msard.2020.102173","article-title":"Neuromyelitis optica in patients with myasthenia gravis: Two case-reports","volume":"43","author":"Castro-Suarez","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.200","article-title":"Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle","volume":"68","author":"Vaknin-Dembinsky","year":"2011","journal-title":"Arch Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.msard.2020.102205","article-title":"Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis","volume":"44","author":"Bates","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.06.038","article-title":"NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy","volume":"275","author":"Kay","year":"2008","journal-title":"J Neurol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.040","article-title":"Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis","volume":"287","author":"Uzawa","year":"2009","journal-title":"J Neurol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: a population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(00)00409-4","article-title":"B cells and antibodies in CNS demyelinating disease","volume":"112","author":"Cross","year":"2001","journal-title":"J Neuroimmunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-510X(89)90005-1","article-title":"Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings","volume":"89","author":"Somer","year":"1989","journal-title":"J Neurol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000234142.41728.a0","article-title":"Abramsky O.Occurrence of CNS demyelinating disease in patients with myasthenia gravis","volume":"67","author":"Gotkine","year":"2006","journal-title":"Neurology."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2008000200023","article-title":"Myasthenia gravis and multiple sclerosis: an uncommon presentation","volume":"66","author":"Lorenzoni","year":"2008","journal-title":"Arq Neuropsiquiatr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.08.016","article-title":"Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: a case report and literature review","volume":"264","author":"Sylvester","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1785491","article-title":"Effects of teriflunomide on B cell subsets in muSK-induced experimental autoimmune myasthenia gravis and multiple sclerosis","volume":"50","author":"Yilmaz","year":"2021","journal-title":"Immunol Invest."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.05.026","article-title":"Paraneoplastic encephalitis associated with myasthenia gravis and Malignant thymoma","volume":"19","author":"Miyazaki","year":"2012","journal-title":"J Clin Neurosci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.11.005","article-title":"Status epilepticus heralding thymomatous paraneoplastic multifocal cortical encephalitis in Myasthenia Gravis","volume":"93","author":"George","year":"2021","journal-title":"Seizure."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.06.016","article-title":"Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up","volume":"115","author":"Aysal","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"577670","DOI":"10.1016\/j.jneuroim.2021.577670","article-title":"Thymoma-associated autoimmune encephalitis with positive Titin antibodies: a case report","volume":"358","author":"Yao Y","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.149336","article-title":"CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis","volume":"80","author":"Monstad","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.02.011","article-title":"Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"100395","DOI":"10.1016\/j.ensci.2022.100395","article-title":"Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies","volume":"27","author":"Satake","year":"2022","journal-title":"E Neurological Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac115","article-title":"British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy","volume":"61","author":"Oldroyd","year":"2022","journal-title":"Rheumatol (Oxford)."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0459-z","article-title":"A case of polymyositis complicated with myasthenic crisis","volume":"26","author":"Yoshidome","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.12.005","article-title":"The co-existence of myasthenia gravis in patients with myositis: a case series","volume":"43","author":"Paik","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-005-0990-z","article-title":"Involvement of mitochondria in myasthenia gravis complicated with dermatomyositis and rheumatoid arthritis: a case report","volume":"109","author":"Shichijo","year":"2005","journal-title":"Acta Neuropathol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10022","article-title":"Concomitant dermatomyositis and myasthenia gravis presenting with respiratory insufficiency","volume":"25","author":"van de Warrenburg","year":"2002","journal-title":"Muscle Nerve"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.39.1108","article-title":"Rapidly progressive polymyositis with elevated antiacetylcholine receptor antibody activity","volume":"39","author":"Yamaguchi","year":"2000","journal-title":"Intern Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-hostdisease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(94)00040-G","article-title":"Coexistence of scleromyositis associated with PM-SCL antibody and myasthenia","volume":"5","author":"Hausmanowa-Petrusewicz","year":"1995","journal-title":"Neuromuscul Disord"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.04.009","article-title":"Inflammatory myopathy associated with myasthenia gravis with and without thymic pathology: Report of four cases and literature review","volume":"16","author":"Santos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B70","doi-asserted-by":"publisher","first-page":"102498","DOI":"10.1016\/j.autrev.2020.102498","article-title":"Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients","volume":"19","author":"Garibaldi","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000535","article-title":"Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology","volume":"6","author":"Uchio","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0364","article-title":"Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease","volume":"93","author":"Ban","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00649.x","article-title":"Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease","volume":"114","author":"Toth","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13254","article-title":"Prevalence and risk of thyroid diseases in myasthenia gravis","volume":"142","author":"Chou","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"B76","doi-asserted-by":"publisher","first-page":"bcr2017220153","DOI":"10.1136\/bcr-2017-220153","article-title":"Hickam's dictum: myasthenia gravis presenting concurrently with Graves' disease","volume":"2017","author":"Sehgal","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat Rev Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.438","article-title":"Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases","volume":"82","author":"Marin\u00f3","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92515-8","article-title":"Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves\u2019 ophthalmopathy","volume":"2","author":"Ludgate","year":"1986","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/BF00180057","article-title":"Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ","volume":"71","author":"Zimmermann","year":"1993","journal-title":"Clin Investig"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2012.01693.x","article-title":"Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan","volume":"127","author":"Chen","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"B83","article-title":"Systemic lupus erythematosus with muscle weakness due to myasthenia gravis","volume":"31","author":"Vinagre","year":"2006","journal-title":"Acta Reumatologica Port"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.07.007","article-title":"Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy","author":"Minchenberg","year":"2018","journal-title":"Clin Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1159\/000365568","article-title":"The course of myasthenia gravis with systemic lupus erythematosus","volume":"72","author":"Bekircan-Kurt","year":"2014","journal-title":"Eur Neurol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.773","article-title":"Systemic lupus erythematosus and myasthenia gravis","volume":"119","author":"Hrycek","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.246058","article-title":"Association of HLA-DR3 and HLA-DR15 polymorphisms with risk of systemic lupus erythematosus","volume":"131","author":"Xue","year":"2018","journal-title":"Chin Med J (Engl)."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cells8101180","article-title":"Mak A.Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2020.08.012","article-title":"Myasthenia gravis and systemic lupus erythematosus: presentation of 5 cases and PubMed review","volume":"36","author":"Jim\u00e9nez-Alonso","year":"2021","journal-title":"Neurologia (Engl Ed)."},{"key":"B91","doi-asserted-by":"publisher","first-page":"134\u2212136","DOI":"10.3346\/jkms.2004.19.1.134","article-title":"Appearance of systemic lupus erythe-matosus in patients with myasthenia gravis following thymectomy: two case reports","volume":"119","author":"Park","year":"2004","journal-title":"J Korean Med Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-006-0465-7","article-title":"A case of systemic lupus erythematosus complicated by pure red cell aplasia and idiopathic portal hypertension after thymectomy","volume":"16","author":"Iwadate","year":"2006","journal-title":"Mod Rheumatol"},{"key":"B93","article-title":"Myasthenia gravis, rheumatoid arthritis, vitiligo, and autoimmune haemolytic anaemia","volume":"64","author":"Durance","year":"1971","journal-title":"Proc R Soc Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880170519","article-title":"Myasthenia gravis and vitiligo","volume":"17","author":"Cruz","year":"1994","journal-title":"Muscle Nerve."},{"key":"B95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00131402-200103000-00014","article-title":"Myasthenia gravis and vitiligo: five new cases","volume":"2","author":"Huang","year":"2001","journal-title":"J Clin Neuromuscul Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14055","article-title":"Comorbidities in vitiligo: comprehensive review","volume":"57","author":"Dahir","year":"2018","journal-title":"Int J Dermatol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2012.118","article-title":"Thymoma associated with myasthenia gravis and Sj\u00f6gren syndrome","volume":"62","author":"Tsai","year":"2013","journal-title":"West Indian Med J"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03003.x","article-title":"Cutaneous manifestations of Sj\u00f6gren's syndrome associated with myasthenia gravis","volume":"141","author":"Ito","year":"1999","journal-title":"Br J Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00939","article-title":"Myasthenia gravis coexisting with primary sj\u00f6gren's syndrome: report of three cases and literature review","volume":"11","author":"Li","year":"2020","journal-title":"Front Neurol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)34006-5","article-title":"Blocking and binding antibodies to intrinsic factor and parietal call antibody in pernicious anemia","volume":"55","author":"Samloff","year":"1968","journal-title":"Gastroenterology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.12.020","article-title":"Cobalamin in subacute combined degeneration and beyond: traditional interpretations and novel theories","volume":"192","author":"Scalabrino","year":"2005","journal-title":"Exp Neurol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott Med J"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60181-9","article-title":"Coexistence of pernicious anemia and myasthenia gravis\u2014a rare combination of autoimmune diseases in Taiwan","volume":"105","author":"Chang","year":"2006","journal-title":"J Formos Med Assoc"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-negative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.229","article-title":"Autoimmune targets of heart and skeletal muscles in myasthenia gravis","volume":"66","author":"Suzuki","year":"2009","journal-title":"Arch Neurol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12234","article-title":"Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies","volume":"21","author":"Suzuki","year":"2014","journal-title":"Eur J Neurol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-04213-7","article-title":"The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis","volume":"41","author":"Ling","year":"2020","journal-title":"Neurol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1223322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:03:36Z","timestamp":1694721816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1223322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":112,"alternative-id":["10.3389\/fimmu.2023.1223322"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1223322","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"article-number":"1223322"}}